Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.5K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.5K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

1.6K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
1.6K
Neurogenesis and Regeneration of Nervous Tissue01:15

Neurogenesis and Regeneration of Nervous Tissue

1.4K
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
1.4K
Neural Regulation01:37

Neural Regulation

42.8K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
42.8K
Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

2.3K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Translingual neural stimulation to improve gait and balance in multiple sclerosis: A randomized controlled trial.

Archives of physical medicine and rehabilitation·2026
Same author

End-of-life communication in the context of MAID: a qualitative study on the perspectives and preferences of individuals living with MS.

BMC palliative care·2026
Same author

Disease Activity Following Cessation of Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2026
Same author

Fingolimod synergizes with anti-PD-1 radioimmunotherapy in an experimental multiple sclerosis model through enhanced lymph node retention and CD8<sup>+</sup> T cell depletion.

Frontiers in medicine·2025
Same author

First-Line Use of Higher-Efficacy Disease-Modifying Therapies in Multiple Sclerosis: Canadian Consensus Recommendations.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2025
Same author

Using Virtual Reality to Assist Students at Academic Risk in Human Anatomy.

Medical science educator·2025
Same journal

Spermidine in Alzheimer's Disease: Evidence from Animal Models and Human Studies.

Degenerative neurological and neuromuscular disease·2026
Same journal

Marked Clinical Improvement in Parkinson's Disease Following Double-Filtration Apheresis: A Case Report.

Degenerative neurological and neuromuscular disease·2026
Same journal

(Z)-Endoxifen as a Potential Modulator of Utrophin Pathways in Duchenne Muscular Dystrophy: A Mechanistic and Transcriptomic Perspective.

Degenerative neurological and neuromuscular disease·2026
Same journal

Agreement and Comparative Performance of Cognitive Testing, Visual MRI Rating, and Automated Brain Morphometry in Older Adults with Suspected Dementia in Uganda.

Degenerative neurological and neuromuscular disease·2026
Same journal

The Gut-Brain Axis in Alzheimer's: From Microbiota Genetics to Stigmasterol's Neuroprotection Mechanism.

Degenerative neurological and neuromuscular disease·2026
Same journal

Effectiveness of Siponimod with Up to 2 Years of Treatment in a Real-World Setting in People with SPMS: Analysis from the Novartis Global Managed Access Program.

Degenerative neurological and neuromuscular disease·2026
See all related articles

Related Experiment Video

Updated: Dec 14, 2025

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.8K

Neurodegeneration in multiple sclerosis involves multiple pathogenic mechanisms.

Michael C Levin1,2, Joshua N Douglas1,2, Lindsay Meyers1

  • 1Veterans Administration Medical Center.

Degenerative Neurological and Neuromuscular Disease
|July 17, 2020
PubMed
Summary
This summary is machine-generated.

Multiple sclerosis (MS) is an autoimmune disease attacking the central nervous system (CNS). This review explores neurodegeneration in MS, highlighting common biological processes underlying this complex condition.

Keywords:
autoantibodieshypoxialipid and one-carbon metabolismnuclear receptorsoxidative stress

More Related Videos

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices
06:36

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

Published on: February 5, 2015

7.4K
Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

5.0K

Related Experiment Videos

Last Updated: Dec 14, 2025

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.8K
An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices
06:36

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

Published on: February 5, 2015

7.4K
Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

5.0K

Area of Science:

  • Neurology
  • Immunology
  • Neurodegeneration

Background:

  • Multiple sclerosis (MS) is a complex autoimmune disease impacting the central nervous system (CNS).
  • The disease's course and neurological disability are highly variable and unpredictable.
  • MS is believed to arise in genetically susceptible individuals following environmental triggers.

Purpose of the Study:

  • To review current theories and evidence on neurodegeneration in MS.
  • To identify common biological processes contributing to neurodegeneration in MS patients.
  • To reframe MS as a neurodegenerative disease initiated by CNS inflammation.

Main Methods:

  • Literature review of existing theories and supporting evidence.
  • Analysis of cellular processes involved in MS pathogenesis.
  • Synthesis of data linking inflammation, demyelination, and neurodegeneration.

Main Results:

  • Neurodegeneration in MS is increasingly understood to occur concurrently with inflammation and demyelination.
  • Diverse biological mechanisms, including cell death and hypoxia, define neurodegeneration in MS.
  • Common pathways contribute to the progressive neurological damage observed in MS.

Conclusions:

  • MS is recognized as a neurodegenerative disease triggered by inflammatory processes in the CNS.
  • Understanding the shared biological underpinnings of neurodegeneration is crucial for MS management.
  • Further research into these common pathways may reveal novel therapeutic targets for MS.